Diagnosis and treatment of multiple sclerosis: a review
MP McGinley, CH Goldschmidt, AD Rae-Grant - Jama, 2021 - jamanetwork.com
Importance Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease
of the central nervous system characterized by inflammatory demyelination with axonal …
of the central nervous system characterized by inflammatory demyelination with axonal …
Ageing and multiple sclerosis
The factor that is most relevant and strongly associated with the clinical course of multiple
sclerosis is chronological age. Very young patients exclusively have relapsing remitting …
sclerosis is chronological age. Very young patients exclusively have relapsing remitting …
Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics
E Kamma, W Lasisi, C Libner, HS Ng… - Journal of …, 2022 - Springer
There are over 15 disease-modifying drugs that have been approved over the last 20 years
for the treatment of relapsing–remitting multiple sclerosis (MS), but there are limited …
for the treatment of relapsing–remitting multiple sclerosis (MS), but there are limited …
Therapeutic advances in multiple sclerosis
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system that
causes significant disability and healthcare burden. The treatment of MS has evolved over …
causes significant disability and healthcare burden. The treatment of MS has evolved over …
[HTML][HTML] Hormone immunoassay interference: a 2021 update
K Ghazal, S Brabant, D Prie… - Annals of laboratory …, 2022 - synapse.koreamed.org
Immunoassays are powerful qualitative and quantitative analytical techniques. Since the first
description of an immunoassay method in 1959, advances have been made in assay …
description of an immunoassay method in 1959, advances have been made in assay …
Smouldering multiple sclerosis: the 'real MS'
G Giovannoni, V Popescu, J Wuerfel… - Therapeutic …, 2022 - journals.sagepub.com
Using a philosophical approach or deductive reasoning, we challenge the dominant clinico-
radiological worldview that defines multiple sclerosis (MS) as a focal inflammatory disease …
radiological worldview that defines multiple sclerosis (MS) as a focal inflammatory disease …
Multiple sclerosis: Diagnosis, disease-modifying therapy and prognosis
BS Travers, BKT Tsang, JL Barton - Australian journal of general …, 2022 - search.informit.org
Background: Multiple sclerosis (MS) is a multifocal inflammatory central nervous system
disorder. There are now many highly effective disease-modifying therapies (DMTs) available …
disorder. There are now many highly effective disease-modifying therapies (DMTs) available …
Secondary progressive multiple sclerosis: a review of clinical characteristics, definition, prognostic tools, and disease-modifying therapies
T Ziemssen, V Bhan, J Chataway, T Chitnis… - Neurology …, 2022 - AAN Enterprises
Many challenges exist in the precise diagnosis and clinical management of secondary
progressive multiple sclerosis (SPMS) because of the lack of definitive clinical, imaging …
progressive multiple sclerosis (SPMS) because of the lack of definitive clinical, imaging …
Oligodendrocyte dysfunction in amyotrophic lateral sclerosis: mechanisms and therapeutic perspectives
S Raffaele, M Boccazzi, M Fumagalli - Cells, 2021 - mdpi.com
Myelin is the lipid-rich structure formed by oligodendrocytes (OLs) that wraps the axons in
multilayered sheaths, assuring protection, efficient saltatory signal conduction and metabolic …
multilayered sheaths, assuring protection, efficient saltatory signal conduction and metabolic …
Multiple sclerosis pathogenesis and updates in targeted therapeutic approaches
ES Vasileiou, KC Fitzgerald - Current allergy and asthma reports, 2023 - Springer
Abstract Purpose of Review In this review, we provide a comprehensive update on current
scientific advances and emerging therapeutic approaches in the field of multiple sclerosis …
scientific advances and emerging therapeutic approaches in the field of multiple sclerosis …